Condition: Recurrent Aphtous Stomatitis · Sponsor: University Hospital, Rouen
The objective of the study is to assess the superiority of apremilast in comparison with placebo to achieve Complete Remission (CR) of oral ulcers at Week 12, in patients with severe Recurrent aphtous stomatitis resistant or intolerant to colchicine.
This description comes directly from the study's public registry record.
Pascal JOLY, Pr · +3323288 · pascal.joly@chu-rouen.fr
Julien BLOT · +3323288 · julien.blot@chu-rouen.fr
Always discuss trial participation with your own doctor first.
| Chu Amiens | Amiens, France | Not Yet Recruiting |
| Ap-Hp Avicenne | Bobigny, France | Recruiting |
| Chu Bordeaux | Bordeaux, France | Recruiting |
| Chru Brest | Brest, France | Recruiting |
| Ch Creteil | Créteil, France | Recruiting |
| Ch Le Mans | Le Mans, France | Recruiting |
| Chu Lille | Lille, France | Recruiting |
| Hcl Hopital Edouard Herriot | Lyon, France | Recruiting |
| Ap-Hm La Timone | Marseille, France | Recruiting |
| Chu Montpellier | Montpellier, France | Recruiting |
| Chu Nantes | Nantes, France | Recruiting |
| CHU NICE | Nice, France | Recruiting |
+ 9 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04227314